Andrea Arleo - Dissemin

Dissemin is shutting down on January 1st, 2025

Language
Login

All papers authored by Andrea Arleo

This paper was not found in any repository, but could be made available legally by the author.

2022 Simona Marzano

ORCID

, Giulia Miglietta, Rita Morigi

ORCID

, Jessica Marinello, Andrea Arleo

ORCID

, Monica Procacci, Alessandra Locatelli, Alberto Leoni, Bruno Pagano

ORCID

, Antonio Randazzo

ORCID

, Jussara Amato

ORCID

, Giovanni Capranico

ORCID

Balancing Affinity, Selectivity, and Cytotoxicity of Hydrazone-Based G-Quadruplex Ligands for Activation of Interferon β Genes in Cancer Cells

Upload

This paper was not found in any repository, but could be made available legally by the author.

Jessica Marinello

ORCID

, Andrea Arleo

ORCID

, Marco Russo, Maria Delcuratolo, Francesca Ciccarelli, Yves Pommier

ORCID

, Giovanni Capranico

ORCID

Topoisomerase I poison-triggered immune gene activation is markedly reduced in human small-cell lung cancers by impairment of the cGAS/STING pathway

Upload

This paper is made freely available by the publisher.

2019 Luigi Angelo Vescovi, Alberto Visioli, Fabrizio Giani

ORCID

, Nadia Trivieri, Nadia Trivier, Riccardo Pracella, Elide Miccinilli, Maria Grazia Cariglia, Orazio Palumbo, Maria Grazia Cariglia, Andrea Arleo

ORCID

, Fabio Dezi, Massimiliano Copetti

ORCID

, Laura Cajola, Silvia Restelli and 12 other authors

Stemness underpinning all steps of human colorectal cancer defines the core of effective therapeutic strategies

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

2017 Alessandra Mangia, Simone Susser, Valeria Piazzolla, Giulio De Stefano, Vincenzo Palmieri, Giancarlo Spinzi, Immacolata Carraturo, Domenico Potenza, Ruggero Losappio, Maria Miscio, Rosanna Santoro, Christoph Sarrazin, Massimiliano Copetti, Ernesto Agostinacchio, Andrea Arleo

ORCID

Sofosbuvir and ribavirin for genotype 2 HCV infected patients with cirrhosis: A real life experience

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

2016 A. Arleo

ORCID

, A. Mangia

The current treatment of hepatitis C

Upload

This paper is made freely available by the publisher.

Alessandra Mangia, Massimiliano Copetti, Maria Miscio, Andrea Arleo

ORCID

, Valeria Piazzolla, Rosanna Santoro, Maria Maddalena Squillante

The combination of daclatasvir and sofosbuvir for curing genotype 2 patients who cannot tolerate ribavirin

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

A. Mangia, A. Arleo

ORCID

, V. Piazzolla, R. Santoro, D. Petruzzellis, M. Miscio, M. M. Squillante

Sustained Virological Responses (SVR) of 97% in Genotype 2 (GT-2) Patients with F3/4 Stage of Fibrosis Treated with Sofosbuvir (SOF) and Weight-Based Ribavirin (RBV): A Real Life, Single Centre Experience

Upload

Missing publications? Search for publications with a matching author name.